Research At CCT

Current Research

Interventional Research

Study Name: Endeavor IV

Number of Patients: 26

Study Description: To test the safety and effectiveness of the Endeavor stent.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: Syntax

Number of Patients: 26

Study Description: To show non-inferior PCI outcomes at 12 months compared with CABG treatment in patients requiring vascularization for 3VD or left main disease.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: Perseus

Number of Patients: 27

Study Description: To evaluate the next generation Taxus (Taxus Element) compared to Taxus Express.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: Elite

Number of Patients: 12

Study Description: To show non inferior safety and efficacy b/w the Cpher Elite and Cypher Bx Velocity.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: Gravitas

Number of Patients: 4

Study Description: To determine whether tailored anti-platelet therapy using the Accumetrics Verify-Now P2Y12 assay reduces MACE after drug-eluting stent implantation.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: ABCD

Number of Patients: 21

Study Description: Assess differences in post-discharge satisfaction between patients randomized to receive early discharge following PCI compared with their counterparts who are randomized to overnight hospital stay in low-risk PCI patients.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: XIENCE

Number of Patients: 23

Study Description: A post-market registry.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: Resolute

Number of Patients:

Study Description: To determine safety and efficacy of the Resolute Zotarolimus-eluting stent.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: Platinum

Number of Patients:

Study Description: To determine safety and efficacy of the Promus Element stent.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: Coral

Number of Patients: 10

Study Description: To answer the question: What is the best treatment for patients who have high blood pressure and renal artery stenosis.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Electrophysiology Research

Study Name: 4196

Number of Patients: 9

Study Description: New LV lead for Biv pacing. Designed to provide a non-invasive option to pace the LV lead from a second location post-implant.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: AVERT AF

Number of Patients: 0

Study Description: Determine if combination of AVJ ablation followed by BiV pacing improves funational status and exercise capacity compared to rate control meds in patients with chronic AF and depressed EF.(Single chamber ICD + meds vs. AVJ ablation + CRTD).

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: MASH

Number of Patients: 2

Study Description: Evaluate ability of Pressure Sensor Defibrillation Lead to meet implant criteria for sensing, pacing, defibrillation and pressure sensing efficacy.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: Optimize RV

Number of Patients: 0

Study Description: Comparing safety and effectiveness RV lead placement in septum vs. apex.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: REASSURE

Number of Patients: 7

Study Description: Determine safety and efficacy of PPM that incorporates capability to treat atrial arrhythmias ATP and sudden cardiac death.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: REDUCE HF

Number of Patients: 1

Study Description: Evaluate safety and effectiveness of CHRONICLE ICD system which combines single, dual or BiV device with ability to record and report intracardiac pressure to assess impact of evaluting heart failure related events.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: RESET

Number of Patients:

Study Description: Assess effect of rate-adaptive pacing in patients with diastolic heart failure and chronotropic incompetence by evaluating functional capacity and quality-of-life changes.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: RIGHT

Number of Patients: 10

Study Description: Post market study comparing incidence of VT/VF therapies delivered for SVT episodes in Guidant vs. Medtronic devices.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: 4195 Chronic Performance

Number of Patients:

Study Description: To evaluate long term perfomance of 4195 lead LV lead.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721

Study Name: VEST/ PREDICTS

Number of Patients: 0

Study Description: VEST: Test hypothesis that non-invasive wearable defib. vest will reduce overall mortality in
60 days post MI in patients with EF <35%
• LifeVest + Opitmal post MI/CHF Treatment vs. Optimal post-Mi Treatment Only
PREDICTS: Develop risk stratification tool that predicts occurrence of fast ventricular arrhythmias that would result in ICD shocks during 5 years after MI and I.D.'s which patients which benefit from ICD vs. REVEAL monitor.
• ICD in participants who still have LVEF < 35% at end of VEST
• REVEAL monitor in those with LVEF >35% at end of VEST.

Location:

Baylor Heart and Vascular Hospital
621 N. Hall Ste.400
Dallas, TX. 75226

Lead Principal Investigator: Call

For further information about this study, please contact: 214-824-8721





	Current Research Interventional Research Study Name: Endeavor IV Number of Patients: 26 Study Description: To test the safety and effectiveness of the Endeavor stent. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: Syntax Number of Patients: 26 Study Description: To show non-inferior PCI outcomes at 12 months compared with CABG treatment in patients requiring vascularization for 3VD or left main disease. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: Perseus Number of Patients: 27 Study Description: To evaluate the next generation Taxus (Taxus Element) compared to Taxus Express. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: Elite Number of Patients: 12 Study Description: To show non inferior safety and efficacy b/w the Cpher Elite and Cypher Bx Velocity. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: Gravitas Number of Patients: 4 Study Description: To determine whether tailored anti-platelet therapy using the Accumetrics Verify-Now P2Y12 assay reduces MACE after drug-eluting stent implantation. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: ABCD Number of Patients: 21 Study Description: Assess differences in post-discharge satisfaction between patients randomized to receive early discharge following PCI compared with their counterparts who are randomized to overnight hospital stay in low-risk PCI patients. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: XIENCE Number of Patients: 23 Study Description: A post-market registry. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: Resolute Number of Patients: Study Description: To determine safety and efficacy of the Resolute Zotarolimus-eluting stent. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: Platinum Number of Patients: Study Description: To determine safety and efficacy of the Promus Element stent. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: Coral Number of Patients: 10 Study Description: To answer the question: What is the best treatment for patients who have high blood pressure and renal artery stenosis. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Electrophysiology Research Study Name: 4196 Number of Patients: 9 Study Description: New LV lead for Biv pacing. Designed to provide a non-invasive option to pace the LV lead from a second location post-implant. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: AVERT AF Number of Patients: 0 Study Description: Determine if combination of AVJ ablation followed by BiV pacing improves funational status and exercise capacity compared to rate control meds in patients with chronic AF and depressed EF.(Single chamber ICD + meds vs. AVJ ablation + CRTD). Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: MASH Number of Patients: 2 Study Description: Evaluate ability of Pressure Sensor Defibrillation Lead to meet implant criteria for sensing, pacing, defibrillation and pressure sensing efficacy. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: Optimize RV Number of Patients: 0 Study Description: Comparing safety and effectiveness RV lead placement in septum vs. apex. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: REASSURE Number of Patients: 7 Study Description: Determine safety and efficacy of PPM that incorporates capability to treat atrial arrhythmias ATP and sudden cardiac death. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: REDUCE HF Number of Patients: 1 Study Description: Evaluate safety and effectiveness of CHRONICLE ICD system which combines single, dual or BiV device with ability to record and report intracardiac pressure to assess impact of evaluting heart failure related events. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: RESET Number of Patients: Study Description: Assess effect of rate-adaptive pacing in patients with diastolic heart failure and chronotropic incompetence by evaluating functional capacity and quality-of-life changes. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: RIGHT Number of Patients: 10 Study Description: Post market study comparing incidence of VT/VF therapies delivered for SVT episodes in Guidant vs. Medtronic devices. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: 4195 Chronic Performance Number of Patients: Study Description: To evaluate long term perfomance of 4195 lead LV lead. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 Study Name: VEST/ PREDICTS Number of Patients: 0 Study Description: VEST: Test hypothesis that non-invasive wearable defib. vest will reduce overall mortality in 60 days post MI in patients with EF <35% • LifeVest + Opitmal post MI/CHF Treatment vs. Optimal post-Mi Treatment Only PREDICTS: Develop risk stratification tool that predicts occurrence of fast ventricular arrhythmias that would result in ICD shocks during 5 years after MI and I.D.'s which patients which benefit from ICD vs. REVEAL monitor. • ICD in participants who still have LVEF < 35% at end of VEST • REVEAL monitor in those with LVEF >35% at end of VEST. Location: Baylor Heart and Vascular Hospital 621 N. Hall Ste.400 Dallas, TX. 75226 Lead Principal Investigator: Call For further information about this study, please contact: 214-824-8721 The information contained in this web site is presented for information purposes only, and is not intended to substitute in any way a consultation with a physician or competent healthcare professional for medical diagnosis and/or treatment.